Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum

Autor: Irene J. Beijert, Anouk E. Hentschel, Johannes Bründl, Eva M. Compérat, Karin Plass, Oscar Rodríguez, Jose D. Subiela Henríquez, Virginia Hernández, Enrique de la Peña, Isabel Alemany, Diana Turturica, Francesca Pisano, Francesco Soria, Otakar Čapoun, Lenka Bauerová, Michael Pešl, H. Maxim Bruins, Willemien Runneboom, Sonja Herdegen, Johannes Breyer, Antonin Brisuda, Ana Calatrava, José Rubio-Briones, Maximilian Seles, Sebastian Mannweiler, Judith Bosschieter, Venkata R.M. Kusuma, David Ashabere, Nicolai Huebner, Juliette Cotte, Laura S. Mertens, Francesco Claps, Alexandra Masson-Lecomte, Fredrik Liedberg, Daniel Cohen, Luca Lunelli, Olivier Cussenot, Soha El Sheikh, Dimitrios Volanis, Jean-François Côté, Morgan Rouprêt, Andrea Haitel, Shahrokh F. Shariat, A. Hugh Mostafid, Jakko A. Nieuwenhuijzen, Richard Zigeuner, Jose L. Dominguez-Escrig, Jaromir Hacek, Alexandre R. Zlotta, Maximilian Burger, Matthias Evert, Christina A. Hulsbergen-van de Kaa, Antoine G. van der Heijden, Lambertus A.L.M. Kiemeney, Viktor Soukup, Luca Molinaro, Paolo Gontero, Carlos Llorente, Ferran Algaba, Joan Palou, James N'Dow, Maria J. Ribal, Theo H. van der Kwast, Marko Babjuk, Richard J. Sylvester, Bas.W.G. van Rhijn

Publikováno v: European Urology Oncology, 6, 2, pp. 214-221
Beijert, I J, Hentschel, A E, Bründl, J, Compérat, E M, Plass, K, Rodríguez, O, Subiela Henríquez, J D, Hernández, V, de la Peña, E, Alemany, I, Turturica, D, Pisano, F, Soria, F, Čapoun, O, Bauerová, L, Pešl, M, Bruins, H M, Runneboom, W, Herdegen, S, Breyer, J, Brisuda, A, Calatrava, A, Rubio-Briones, J, Seles, M, Mannweiler, S, Bosschieter, J, Kusuma, V R M, Ashabere, D, Huebner, N, Cotte, J, Mertens, L S, Claps, F, Masson-Lecomte, A, Liedberg, F, Cohen, D, Lunelli, L, Cussenot, O, el Sheikh, S, Volanis, D, Côté, J-F, Rouprêt, M, Haitel, A, Shariat, S F, Mostafid, A H, Nieuwenhuijzen, J A, Zigeuner, R, Dominguez-Escrig, J L, Hacek, J, Zlotta, A R, Burger, M, Evert, M, Hulsbergen-van de Kaa, C A, van der Heijden, A G, Kiemeney, L A L M, Soukup, V, Molinaro, L, Gontero, P, Llorente, C, Algaba, F, Palou, J, N'Dow, J, Ribal, M J, van der Kwast, T H, Babjuk, M, Sylvester, R J & van Rhijn, B W G 2023, ' Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum ', European Urology Oncology, vol. 6, no. 2, pp. 214-221 . https://doi.org/10.1016/j.euo.2023.01.004
European Urology Oncology, 6(2), 214-221. Elsevier BV

Contains fulltext : 294430.pdf (Publisher’s version ) (Open Access) BACKGROUND: Ta grade 3 (G3) non-muscle-invasive bladder cancer (NMIBC) is a relatively rare diagnosis with an ambiguous character owing to the presence of an aggressive G3 componen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0357aac834157cb127751b6ccb41830

Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men

Autor: O. Sjoerd Klaver, Hans de Jong, Christina A. Hulsbergen-van de Kaa, Jeroen Veltman, Wim Van Criekinge, Inge M. van Oort, Marloes van der Leest, Rianne J. Hendriks, Gerjon Hannink, J.P. Michiel Sedelaar, Jelle O. Barentsz, Peter F.A. Mulders, Jack A. Schalken, Anglita YantiSetiasti, Bas Israël, Erik B. Cornel, E. David Crawford

Publikováno v: PROSTATE CANCER AND PROSTATIC DISEASES
Prostate Cancer and Prostatic Diseases, 24, 1110-1119
Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases, 24, 4, pp. 1110-1119

Background Risk stratification in men with suspicion of prostate cancer (PCa) requires reliable diagnostic tests, not only to identify high-grade PCa, also to minimize the overdetection of low-grade PCa, and reduction of “unnecessary” prostate MR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70400b603d306e99244a7f46d445d3ec
https://hdl.handle.net/2066/242775

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study

Autor: Jelle O. Barentsz, Inge M. van Oort, Anwar R. Padhani, Gerjon Hannink, Anglita Yanti Setiasti, Huib van den Hout, Rianne J. Hendriks, Martijn Hoogenboom, Dirk Bakker, Bas Israël, Frans M.J. Debruyne, Erik B. Cornel, Sjoerd O. Klaver, Christina A. Hulsbergen-van de Kaa, Marloes van der Leest, Michiel Sedelaar, Patrik Zamecnik, Jeroen Veltman, Hans van der Lelij, Maroeska M. Rovers

Publikováno v: European Urology, 75, 4, pp. 570-578
European urology, 75(4), 570-578. Elsevier
European Urology, 75, 570-578
International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology

Background: There is growing interest to implement multiparametric magnetic resonance imaging (mpMRI) and MR-guided biopsy (MRGB) for biopsy-naïve men with suspected prostate cancer. Objective: Primary objective was to compare and evaluate an MRI pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4dabd8517eea50ca2a54d585ad1c9f
https://doi.org/10.1016/j.eururo.2018.11.023

Intraoperatieve detectie van het heldercellig niercelcarcinoom met 111In-girentuximab-IRDye800CW: proof-of-principlestudie

Autor: Johan F. Langenhuijsen, Egbert Oosterwijk, Constantijn H.J. Muselaers, Peter F.A. Mulders, Otto Boerman, Wim J.G. Oyen, Mark Rijpkema, Christina A. Hulsbergen-van de Kaa, Marlène C.H. Hekman

Publikováno v: Tijdschrift voor Urologie. 9:42-53

Het doel van deze studie is de veiligheid en toepasbaarheid van carbonzuuranhydrase IX (CAIX)-targeted dual-modality imaging bij een heldercellig niercelcarcinoom (ccRCC) te onderzoeken. Zeven dagen voor de partiele of totale nefrectomie werden patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4999b4a928d12a2f11789afc43d890fb
https://doi.org/10.1007/s13629-018-0242-3

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel[Formula presented]

Autor: Jakko A. Nieuwenhuijzen, Lenka Bauerová, Laura S. Mertens, Paolo Gontero, Francesca Pisano, Jean François Coté, Karin Plass, Anouk E. Hentschel, Enrique de la Peña, Carlos Llorente, Francesco Soria, Johannes Bründl, Shahrokh F. Shariat, Amir Hugh Mostafid, Michael Pešl, Isabel Alemany, Sonja Herdegen, Richard Sylvester, Antoine G. van der Heijden, Bas W.G. van Rhijn, Matthias Evert, Dimitrios Volanis, Sebastian Mannweiler, Venkata R.M. Kusuma, David Ashabere, Theo van der Kwast, Juliette Cotte, James N'Dow, Alexandre R. Zlotta, Jose D. Subiela Henríquez, Willemien Runneboom, Virginia Hernández, Ana Calatrava, Jaromir Hacek, Viktor Soukup, Oscar Rodríguez, Lambertus A. Kiemeney, Morgan Rouprêt, Johannes Breyer, Andrea Haitel, Soha El Sheikh, Harman Max Bruins, Marko Babjuk, Daniel Cohen, J. Domínguez-Escrig, Eva Compérat, Maximilian Seles, José Rubio-Briones, Nicolai A. Huebner, Diana Turturica, Luca Molinaro, Ferran Algaba, Luca Lunelli, Judith Bosschieter, Antonin Brisuda, Joan Palou, Richard Zigeuner, Maximilian Burger, Olivier Cussenot, Otakar Čapoun, Christina A. Hulsbergen-van de Kaa

Publikováno v: European Urology, 79(4), 480-488. Elsevier
EUROPEAN UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Sylvester, R J, Rodríguez, O, Hernández, V, Turturica, D, Bauerová, L, Bruins, H M, Bründl, J, van der Kwast, T H, Brisuda, A, Rubio-Briones, J, Seles, M, Hentschel, A E, Kusuma, V R M, Huebner, N, Cotte, J, Mertens, L S, Volanis, D, Cussenot, O, Subiela Henríquez, J D, de la Peña, E, Pisano, F, Pešl, M, van der Heijden, A G, Herdegen, S, Zlotta, A R, Hacek, J, Calatrava, A, Mannweiler, S, Bosschieter, J, Ashabere, D, Haitel, A, Côté, J F, El Sheikh, S, Lunelli, L, Algaba, F, Alemany, I, Soria, F, Runneboom, W, Breyer, J, Nieuwenhuijzen, J A, Llorente, C, Molinaro, L, Hulsbergen-van de Kaa, C A, Evert, M, Kiemeney, L A L M, N'Dow, J, Plass, K, Čapoun, O, Soukup, V, Dominguez-Escrig, J L, Cohen, D, Palou, J, Gontero, P, Burger, M, Zigeuner, R, Mostafid, A H, Shariat, S F, Rouprêt, M, Compérat, E M, Babjuk, M & van Rhijn, B W G 2021, ' European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade : An Update from the EAU NMIBC Guidelines Panel[Formula presented] ', European Urology, vol. 79, no. 4, pp. 480-488 . https://doi.org/10.1016/j.eururo.2020.12.033
European Urology, 79, 4, pp. 480-488
European Urology, 79, 480-488

Background: The European Association of Urology (EAU) prognostic factor risk groups for non–muscle-invasive bladder cancer (NMIBC) are used to provide recommendations for patient treatment after transurethral resection of bladder tumor (TURBT). The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0851fd7fae061679d8b2c898aa1490e3
https://research.vumc.nl/en/publications/a17e38be-9d38-4c05-bb32-8a8949f3a74c